Chaim Mond, MD
Rheumatology · Columbia, MDNPI 1992809008
Payments from drug & device makers
Across 34 payments — averaging $20.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$170
- Amgen$150
- Pfizer$90
- Johnson & Johnson$73
- Hikma Pharmaceuticals USA$48
- Novo Nordisk$39
- plus $128 from 7 others
What the payments were for
- Food & beverage$697100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 7 | $170 |
| Amgen | 7 | $150 |
| Pfizer | 5 | $90 |
| Johnson & Johnson | 3 | $73 |
| Hikma Pharmaceuticals USA | 3 | $48 |
| Novo Nordisk | 2 | $39 |
| IBSA Pharma Inc. | 1 | $21 |
| Sanofi | 1 | $20 |
| Shire North American Group Inc | 1 | $20 |
| Bristol Myers Squibb | 1 | $20 |
| Merck | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
How this compares
$697 in reported general payments places this provider in the 25th percentile of 173 rheumatology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MethotrexateMethotrexate Sodium | 112 | $3,385 |
| Hydroxychloroquine Sulfate | 80 | $2,649 |
| Gabapentin | 81 | $1,104 |
| Allopurinol | 68 | $959 |
| Prednisone | 120 | $750 |
| Duloxetine Hcl | 37 | $695 |
| Diclofenac Sodium | 13 | $617 |
| Pregabalin | 27 | $555 |
| Tramadol Hcl | 78 | $542 |
| Cyclobenzaprine Hcl | 24 | $420 |
| Omeprazole | 13 | $417 |
| Meloxicam | 37 | $391 |
| Alendronate Sodium | 21 | $371 |
| Tizanidine Hcl | 44 | $268 |
| Folic Acid | 17 | $150 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Columbia
- James BellorColumbia$80K
- Marlyn LorenzoColumbia$42K
- Thomas LangColumbia$34K
- Moe ZanColumbia$25K
- Stephen GeorgeColumbia$21K
- Shabnam AliColumbia$20K
- Steven KleinHagerstown$3.4M
- Herbert BarafWheaton$1.4M
- Paul DemarcoWheaton$1.4M
- Thomas Grader BeckBaltimore$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.